Sona Nanotech to Present at the OTC Markets’ Life Sciences Virtual Investor Forum On September 17th
HALIFAX, Nova Scotia, Sept.
11, 2026 (GLOBE NEWSWIRE) — Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF), an oncology company developing a therapy to increase the limited efficacy of immunotherapy drugs, today announced th
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on financialpost.com — the content belongs to Financial Post.